Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Genetics
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities

07, Jun 2026

2
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Insights from UK Biobank

06, Jun 2026

3
Polygenic Risk Scoring for Multiple Sclerosis: Ancestry-Dependent Performance and the Need for Equitable Genomic Prediction
Genetics
Polygenic Risk Scoring for Multiple Sclerosis: Ancestry-Dependent Performance and the Need for Equitable Genomic Prediction

05, Jun 2026

4
Genetic Architecture of Multiple Sclerosis Across South Asian and African Ancestries
Genetics
Genetic Architecture of Multiple Sclerosis Across South Asian and African Ancestries

04, Jun 2026

5
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Dutch Birth-Year Cohort
Genetics
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Dutch Birth-Year Cohort

03, Jun 2026

Categories:
Genetics
Moving Beyond "One Drug Fits All" in Multiple Sclerosis: The Dawn of Personalized Medicine
Genetics
Moving Beyond "One Drug Fits All" in Multiple Sclerosis: The Dawn of Personalized Medicine

27, Apr 2025

Decoding MS Treatment Response: Could Our Genes Hold the Key to Better Outcomes with Glatiramer Acetate?
Genetics
Decoding MS Treatment Response: Could Our Genes Hold the Key to Better Outcomes with Glatiramer Acetate?

28, Apr 2025

Multiple Sclerosis Treatment Response and the Role of Genetic Variations
Genetics
Multiple Sclerosis Treatment Response and the Role of Genetic Variations

29, Apr 2025

Genetic Variations Influencing Glatiramer Acetate Response in Multiple Sclerosis: A Pharmacogenomic Perspective
Genetics
Genetic Variations Influencing Glatiramer Acetate Response in Multiple Sclerosis: A Pharmacogenomic Perspective

30, Apr 2025